April 29th 2025
Experts at Asembia’s AXS25 Summit discussed the economics of specialty pharmacy for rare diseases, addressing high treatment costs and strategies for balancing innovation.
9 in 10 Americans Support Federal Intervention in Drug Prices in Response to COVID-19 Pandemic
June 19th 2020According to a new study by West Health and Gallup, 88% of US adults support the federal government directly negotiating the price of a COVID-19 treatment with a drug manufacturer upon its availability due to concerns regarding raised drug prices.
Survey Shows Time-to-Fill Delays of Up to 10 Days for Specialty Prescriptions
May 14th 2020Survey finds that nearly two-thirds of specialty pharmacists spend more than 15 minutes on the phone to fill 1 prescription, whereas 79% of specialty pharmacists seek additional information from clinicians at least 3 times in an average day.